Louisiana 2018 Regular Session

Louisiana House Bill HB826

Introduced
4/3/18  
Introduced
4/3/18  
Refer
4/4/18  
Refer
4/4/18  
Report Pass
4/17/18  

Caption

Provides relative to specialty pharmacy licenses for marijuana dispensing pharmacies

Impact

If enacted, HB 826 would significantly influence state laws regarding medical marijuana distribution. By repealing the limit on pharmacy licenses, the bill allows for a potential increase in dispensaries, leading to wider access for patients in need of medical marijuana. The provision to prioritize minority-owned businesses aligns with broader state goals of economic inclusion and diversity. Furthermore, the enhanced financial stability requirements for licensed entities may ensure a more robust and compliant industry, providing accountability in the operation of marijuana dispensing pharmacies.

Summary

House Bill 826 focuses on the licensing of pharmacies for the dispensing of medical marijuana in Louisiana. It proposes to amend current regulations, particularly concerning the number of licenses issued by the Louisiana Board of Pharmacy. Specifically, the bill seeks to eliminate the existing limit of ten licenses and ensures that at least four licenses are granted to minority-owned businesses. This legislative measure is aimed at increasing access to medical marijuana, particularly in underserved communities, while enforcing that only board-licensed pharmacists can operate these dispensing pharmacies.

Sentiment

The sentiment surrounding HB 826 appears to be cautiously optimistic among supporters, particularly within communities advocating for increased access to medical marijuana. Proponents highlight the importance of representation in the cannabis industry and view the bill as a step toward greater equity. However, there are concerns from some factions about the implications of a less regulated market, such as the potential for oversaturation of pharmacies or challenges in maintaining quality control. This dual sentiment indicates a divide between those prioritizing access and equity versus those expressing caution regarding overall regulation.

Contention

Notable points of contention regarding HB 826 include the balance between expanding access to medical marijuana through increased pharmacy licenses and ensuring the quality and safety of products dispensed. Opponents may argue that losing the limit on pharmacy licenses could lead to an overabundance of dispensaries, which may dilute the market and affect standards. Additionally, the requirement for minority ownership in pharmacies has sparked discussions about effectiveness versus intention; some critics worry that without careful oversight, the intended goals of equity may not be achieved in practice.

Companion Bills

No companion bills found.

Similar Bills

LA HB376

Provides relative to the regulation of medical marijuana

LA HB697

Reforms the state systems for regulating the production of marijuana for therapeutic use and for the dispensing of such product (EN INCREASE SG EX See Note)

LA HB460

Provides relative to the dispensing of medical marijuana

LA SB143

Enacts Alison Neustrom Act and provides relative to prescribed marijuana for therapeutic uses and the development of rules and regulations by the Louisiana Board of Pharmacy and the Louisiana State Board of Medical Examiners. (gov sig)

LA HB244

Provides relative to marijuana pharmacies, creates the Medical Marijuana Affordable Access Council, and authorizes the regulation of medical marijuana prices

LA HB579

Provides relative to the authorization for therapeutic use of marijuana

LA HB768

Provides for the licensure of therapeutic marijuana pharmacies

LA SB271

Provides for medical marijuana. (See Act) (RE1 SEE FISC NOTE GF EX See Note)